Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Medice Arzneimittel Putter GmbH & Co. K.G

Medicines register · Ireland

Medice Arzneimittel Putter GmbH & Co. K.G — licensed medicines

22 medicines held by Medice Arzneimittel Putter GmbH & Co. K.G on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/1-2

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/15-16

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 2 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/3-4

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 20 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/021-22

Epoetin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 3 000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/412/5-6

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 30 000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023-24

Epoetin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 4 000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/412/7-8

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 40 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/025-26

Epoetin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 5 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/9-10

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 6 000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/412/11-12

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 8 000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/13-14

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Medikinet 10 mg tablets PA1555/001/007

Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet 20 mg tablets PA1555/001/008

Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet 5 mg tablets PA1555/001/006

Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet MR 10mg modified – release capsules, hard PA1555/001/002

Methylphenidate hydrochloride, Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet MR 20mg modified – release capsules, hard PA1555/001/003

Methylphenidate hydrochloride, Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet MR 30mg modified – release capsules, hard PA1555/001/004

Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet MR 40mg modified – release capsules, hard PA1555/001/005

Methylphenidate hydrochloride, Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

Medikinet MR 5mg modified – release capsules, hard PA1555/001/001

Methylphenidate hydrochloride, Methylphenidate hydrochloride

Medice Arzneimittel Putter GmbH & Co. K.G

Marketed

VAFSEO 150 mg Film-coated tablet EU/1/23/1725/001-002

Vadadustat

Medice Arzneimittel Putter GmbH & Co. K.G

—

VAFSEO 300 mg Film-coated tablet EU/1/23/1725/003-004

Vadadustat

Medice Arzneimittel Putter GmbH & Co. K.G

—

VAFSEO 450 mg Film-coated tablet EU/1/23/1725/005-006

Vadadustat

Medice Arzneimittel Putter GmbH & Co. K.G

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines/company/medice-arzneimittel-putter-gmbh-co-k-g

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.